Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Completed · Phase 1

Conditions studied: Malignant Mesothelioma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Interferon alfa may interfere with the growth of cancer cells. Combining chemotherapy, radiation therapy, and interferon alfa may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of cisplatin plus interferon alfa followed by surgery and interferon alfa plus radiation therapy in treating patients with malignant pleural mesothelioma.

Key facts

Study ID

NCT00003263

Run by

Fox Chase Cancer Center

People needed

6

Starts

1996-08-01

Expected to finish

2000-11-01

Last updated by the study team

2013-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Office of S. Terry Kraus — Marrero, Louisiana, United States
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
• Virginia Oncology Associates — Newport News, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.